跳至主要内容
临床试验/CTRI/2017/04/008423
CTRI/2017/04/008423招募中4 期

A Clinicocomparative study on kushmandbeej taila uttarbasti and matrabasti in the management of Mootraghata w.s.r. to Benign Prostatic Hyperplasia.

Govt Akhandanand Ayurved College Hospital0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients presenting with classical signs & symptoms of BPH.
  • Patients of any cast, religion.
  • Controlled case of Diabetes mellitus and Hypertension.
  • Prostate size (volume) up to 50 cc in USG KUB.
  • post void residual volume upto 100 cc

排除标准

  • Patients with malignancy.
  • Prostate size (volume) more than 50cc in USG.
  • post void residual volume more than 100cc.
  • Patients with systemic diseases like Tuberculosis, HIV, HBsAg, Uncontrolled DM and HTN.
  • Patients with coagulopathy like Haemophilia and Von Will brandâ??s disease.
  • Vulnerable group of people like mentally ill.

研究者

发起方
Govt Akhandanand Ayurved College Hospital

相似试验

Treatment of BPH with kushmandbeejtaila | 临床试验